Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis.
Can somatosensory evoked potentials predict disease course in early multiple sclerosis patients?
Teriflunomide for the treatment of relapsing multiple sclerosis: a review of clinical data.
A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis.
Activation-induced cell death in T lymphocytes from multiple sclerosis patients.
A PheWAS approach in studying HLA-DRB1*1501.
Combining Self-help and Professional Help to Minimize Barriers to Physical Activity in Persons With Multiple Sclerosis: A Trial of the "Blue Prescription" Approach in New Zealand.
Reimbursement and market access of multiple sclerosis products in the United States.
Facial and Bodily Emotion Recognition in Multiple Sclerosis: The Role of Alexithymia and Other Characteristics of the Disease.
Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
[Stem cell transplantation for multiple sclerosis : Hamburg experiences and state of international research].
Parallel changes in structural and functional measures of optic nerve myelination after optic neuritis.
Safety and efficacy of reduced fingolimod dosage treatment.
Novel molecular insights into classical and alternative activation states of microglia as revealed by SILAC-based proteomics.
The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients.
Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease.
Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
Nutraceuticals against Neurodegeneration: A Mechanistic Insight.
Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.
In vivo immunomodulatory effect of the lectin from edible mushroom Agaricus bisporus.
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial.
Validity of an Observation Method for Assessing Pain Behavior in Individuals With Multiple Sclerosis.
A Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple Sclerosis.
Pages
« first
‹ previous
…
440
441
442
443
444
445
446
447
448
…
next ›
last »